0
0

Cart (0)

Home > NDSRI's > Linagliptin

Linagliptin - NDSRI's
Wishlist
Select options

tert-butyl (R)-(1-nitrosopiperidin-3-yl)carbamate

  • CAT NUMBER DCTI-C-2734
  • CAS NUMBER NA
  • MOLECULAR FORMULA C10H19N3O3
  • MOLECULAR WEIGHT 229.28
Select options
Wishlist
References
FAQ's

References

  1. Himmelsbach, Frank; Langkopf, Elke; Eckhardt, Matthias; Mark, Michael; Maier, Roland; Lotz, Ralf Richard Hermann; Tadayyon, Mohammad,8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions, Boehringer Ingelheim Pharma G.m.b.H. & Co. K.-G., Germany, US7407955B2, August 5, 2008
  2. El-Bagary, Ramzia Ismail; Elkady, Ehab Farouk; Ayoub, Bassam Mahfouz, Spectrofluorometric determination of linagliptin in bulk and in pharmaceutical dosage form,European Journal of Chemistry, Volume: 5, Issue: 2, Pages: 380-382, 3 pp., 2014

Frequently Asked Questions

Regulatory guidelines outline the necessary documentation and reporting of Linagliptin impurities to ensure transparency and accountability.

Genotoxicity testing is typically conducted to assess the potential of Linagliptin impurities to cause DNA damage or mutations.

Improper manufacturing processes, such as poor handling or contamination, can contribute to the formation of impurities in Linagliptin.

Linagliptin impurities should be stored at a controlled room temperature, usually between 2-8 °C.

Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.

Back to Top
Product has been added to your cart